There is one clear solution that continues to emerge across all credible research: More staffing leads to better care.

Up to 60 percent of older adults live with persistent muscle pain, but there’s a lot you can do to ease that discomfort.

Idorsia gets FDA approval of Tryvio (aprocitentan) for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that use.